Brett M. Stevens, Ph.D. - Publications

Affiliations: 
2010 University of Rochester, Rochester, NY 
Area:
Glial development, multiple sclerosis, brain tumours

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Stevens B, Maxson J, Tyner J, Smith CA, Gutman JA, Robinson W, Jordan CT, Lee CK, Swisshelm K, Tobin J, Wei Q, Schowinsky J, Rinella S, Lee HG, Pollyea DA. Clonality of Neutrophilia Associated with Plasma Cell Neoplasms: Report of a SETBP1 Mutation and Analysis of a Single Institution Series. Leukemia & Lymphoma. 1-22. PMID 26389776 DOI: 10.3109/10428194.2015.1094697  0.68
2015 Noble M, Mayer-Pröschel M, Li Z, Dong T, Cui W, Pröschel C, Ambeskovic I, Dietrich J, Han R, Yang YM, Folts C, Stripay J, Chen HY, Stevens BM. Redox biology in normal cells and cancer: restoring function of the redox/Fyn/c-Cbl pathway in cancer cells offers new approaches to cancer treatment. Free Radical Biology & Medicine. 79: 300-23. PMID 25481740 DOI: 10.1016/j.freeradbiomed.2014.10.860  0.68
2014 Stevens BM, Folts CJ, Cui W, Bardin AL, Walter K, Carson-Walter E, Vescovi A, Noble M. Cool-1-mediated inhibition of c-Cbl modulates multiple critical properties of glioblastomas, including the ability to generate tumors in vivo. Stem Cells (Dayton, Ohio). 32: 1124-35. PMID 24458840 DOI: 10.1002/stem.1644  0.68
2013 Chen HY, Yang YM, Stevens BM, Noble M. Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells. Embo Molecular Medicine. 5: 723-36. PMID 23606532 DOI: 10.1002/emmm.201202140  0.68
2008 Wang PY, Young F, Chen CY, Stevens BM, Neering SJ, Rossi RM, Bushnell T, Kuzin I, Heinrich D, Bottaro A, Jordan CT. The biologic properties of leukemias arising from BCR/ABL-mediated transformation vary as a function of developmental origin and activity of the p19ARF gene. Blood. 112: 4184-92. PMID 18755985 DOI: 10.1182/blood-2008-02-142190  0.68
2008 Percent SF, Frischer ME, Vescio PA, Duffy EB, Milano V, McLellan M, Stevens BM, Boylen CW, Nierzwicki-Bauer SA. Bacterial community structure of acid-impacted lakes: what controls diversity? Applied and Environmental Microbiology. 74: 1856-68. PMID 18245245 DOI: 10.1128/AEM.01719-07  0.68
Show low-probability matches.